Beneficial Effects of the Very-Low-Calorie Ketogenic Diet on the Symptoms of Male Accessory Gland Inflammation

• Published in: Nutrients 2022-03, Vol.14 (5), p.1081
• Main Authors: Condorelli, Rosita A, Aversa, Antonio, Basile, Livia, Cannarella, Rossella, Mongioì, Laura M, Cimino, Laura, Perelli, Sarah, Caprio, Massimiliano, Cimino, Sebastiano, Calogero, Aldo E, La Vignera, Sandro
• Format: Article
• Language: English
• Subjects: Accessory gland; Body weight; Body weight loss; Calories; Carbohydrates; Diet; Diet, Ketogenic; Discomfort; Domains; Endocrinology; Erectile dysfunction; Evaluation; Glycemic index; Heart rate; High fat diet; Humans; Hypocaloric diet; Inflammation; Ketogenesis; Legumes; Low carbohydrate diet; MAGI; Male; male accessory gland infection; Meals; Mediterranean diet; Metabolism; Nutrient deficiency; Nutrition research; Obesity; Overweight; Pain; Patients; Physical fitness; Prostate; Proteins; Quality of Life; Questionnaires; Sexual behavior; urinary symptoms; Urinary tract; very-low-calorie ketogenic diet; VLCKD; Weight loss
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu14051081

Obesity exposes individuals to the risk of chronic inflammation of the prostate gland. A longitudinal clinical study was conducted on selected overweight/obese patients with male accessory gland inflammation (MAGI) to evaluate the effects of body weight loss on their urogenital symptoms. One hundred patients were selected and assigned to two groups undergoing two different nutritional programs. The first group ( = 50) started a Mediterranean diet (MedDiet) and the second ( = 50) a very-low-calorie ketogenic diet (VLCKD). Before and after three months on the diet, each patient was evaluated for body weight, waist circumference, and MAGI symptoms. The MAGI was assessed using the Structured Interview about MAGI (SI-MAGI), a questionnaire previously designed to assess the symptoms of MAGI. The questionnaire explores four domains, including urinary symptoms, ejaculatory pain or discomfort, sexual dysfunction, and impaired quality of life. Finally, in the two groups, the frequency of an α-blocker used to treat urinary tract symptoms was also evaluated. Patients on MedDiet experienced significant amelioration in urinary symptoms and quality of life. Patients under VLCKD reported not only significant improvement of the same parameters, but also in ejaculatory pain/discomfort and sexual dysfunction. Finally, the percentage of patients on VLCKD taking the α-blocker decreased significantly. Moreover, patients under VLCKD showed a greater loss of body weight than those following the MedDiet. The results of this study support the effectiveness of VLCKD in improving the symptoms of patients with MAGI. This improvement involved all of the domains of the SI-MAGI questionnaire and became manifest in a relatively short time. We suggest that a ketogenic nutritional approach can be used in overweight/obese patients with MAGI.